These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 2964174)
41. [The basal ganglia. A clinical and physiopathological approach (author's transl)]. Rondot P J Physiol (Paris); 1981 Apr; 77(1):119-30. PubMed ID: 6453222 [TBL] [Abstract][Full Text] [Related]
42. Swallowing disorders in the elderly. Schindler JS; Kelly JH Laryngoscope; 2002 Apr; 112(4):589-602. PubMed ID: 12150508 [TBL] [Abstract][Full Text] [Related]
43. Movement disorders. Colcher A Clin Podiatr Med Surg; 1999 Jan; 16(1):127-39. PubMed ID: 9929775 [TBL] [Abstract][Full Text] [Related]
44. Electrophysiologic patterns of oral-pharyngeal swallowing in parkinsonian syndromes. Alfonsi E; Versino M; Merlo IM; Pacchetti C; Martignoni E; Bertino G; Moglia A; Tassorelli C; Nappi G Neurology; 2007 Feb; 68(8):583-9. PubMed ID: 17310027 [TBL] [Abstract][Full Text] [Related]
45. Prepharyngeal dysphagia in Parkinson's disease. Leopold NA; Kagel MC Dysphagia; 1996; 11(1):14-22. PubMed ID: 8556872 [TBL] [Abstract][Full Text] [Related]
46. Contribution of dopaminergic and glutamatergic mechanisms to the pathogenesis of motor response complications in Parkinson's disease. Chase TN; Engber TM; Mouradian MM Adv Neurol; 1996; 69():497-501. PubMed ID: 8615171 [No Abstract] [Full Text] [Related]
47. [An autopsy case of Parkinson's disease manifesting hyperphagia and dysphagia followed by severe achalasia (disorder of motility) of the esophagus]. Yoshimura N; Shoji M; Matsui T No To Shinkei; 1982 Aug; 34(8):741-6. PubMed ID: 6957204 [No Abstract] [Full Text] [Related]
48. Tardive and withdrawal dyskinesia in autistic children: a prospective study. Campbell M; Adams P; Perry R; Spencer EK; Overall JE Psychopharmacol Bull; 1988; 24(2):251-5. PubMed ID: 3212157 [No Abstract] [Full Text] [Related]
49. Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders. Crossman AR Neuroscience; 1987 Apr; 21(1):1-40. PubMed ID: 2955248 [No Abstract] [Full Text] [Related]
50. The emerging role of clozapine in the treatment of movement disorders. Factor SA; Friedman JH Mov Disord; 1997 Jul; 12(4):483-96. PubMed ID: 9251065 [TBL] [Abstract][Full Text] [Related]
52. Movement disorders and pregnancy: a review of the literature. Kranick SM; Mowry EM; Colcher A; Horn S; Golbe LI Mov Disord; 2010 Apr; 25(6):665-71. PubMed ID: 20437535 [TBL] [Abstract][Full Text] [Related]
53. Medical management of motor manifestations of Huntington disease. McCusker EA; Loy CT Handb Clin Neurol; 2017; 144():141-150. PubMed ID: 28947112 [TBL] [Abstract][Full Text] [Related]
54. What are the primary nutritional issues for a patient with Parkinson's disease? Marcason W J Am Diet Assoc; 2009 Jul; 109(7):1316. PubMed ID: 19559148 [No Abstract] [Full Text] [Related]
55. Impairment of optokinetic nystagmus in patients with tardive dyskinesia. Lipper S Arch Gen Psychiatry; 1973 Mar; 28(3):331-3. PubMed ID: 4143946 [No Abstract] [Full Text] [Related]
56. Cinefluorographic evaluation of swallowing in patients with involuntary movements. Massengill R; Nashold BS Confin Neurol; 1969; 31(4):269-72. PubMed ID: 5366522 [No Abstract] [Full Text] [Related]
57. The need of reliable warning signs for dysphagia in Parkinson's disease: an often-overlooked issue. Motolese F; Di Lazzaro V; Marano M Expert Rev Gastroenterol Hepatol; 2020 Dec; 14(12):1227-1228. PubMed ID: 32969720 [No Abstract] [Full Text] [Related]